Combination therapy to checkmate Glioblastoma: clinical challenges and advances
Abstract Combination therapy is increasingly becoming the cornerstone of current day antitumor therapy. Glioblastoma multiforme is an aggressive brain tumor with a dismal median survival post diagnosis and a high rate of disease recurrence. The poor prognosis can be attributed to unique treatment li...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-10-01
|
Series: | Clinical and Translational Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40169-018-0211-8 |